Overview

Efficacy of DCVAC/OvCa Plus Standard of Care in Relapsed Platinum Resistant Epithelial Ovarian Carcinoma

Status:
Terminated
Trial end date:
2016-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether DCVAC/OvCa added to chemotherapy may result in prolongation of Overall Survival (OS).
Phase:
Phase 2
Details
Lead Sponsor:
SOTIO a.s.
Treatments:
Albumin-Bound Paclitaxel
Doxorubicin
Liposomal doxorubicin
Paclitaxel
Topotecan